 |
 |

Cystic Fibrosis Survival RatesThe Influences of Allergy and Pseudomonas aeruginosa
Robert W. Wilmott, MD, MRCP(UK);
Saba L. Tyson;
Duncan J. Matthew, FRCP(UK)
Am J Dis Child. 1985;139(7):669-671.
Abstract
 |  |
Allergy and chronic Pseudomonas aeruginosa (PA) infection are two factors that possibly affect the clinical severity of cystic fibrosis pulmonary disease, although the role of allergy is controversial. We have examined the effects of these factors on actuarial survival rates in 117 children with cystic fibrosis who were skin tested in 1974 and classified as allergic (A+) or nonallergic (A–) by their reactions to 12 prick tests with common environmental allergens. Patients were also classified according to whether or not they had chronic pulmonary infection with PA in 1974 (PA-positive or PA-negative). Survival rates in A + patients were not significantly different from those in the A– group (percent survival to age 16 years, 67% vs 80%), whereas the PA+ group had significantly worse survival rates than the PA– group (percent survival to age 16 years, 53% vs 84%). There was no significant interaction between allergic skin reactions and either age at onset of chronic PA Infection or subsequent duration of survival.
(AJDC 1985;139:669-671)
Author Affiliations
From the Respiratory Unit, The Hospital for Sick Children, London. Dr Wilmott is now with The Children's Hospital of Philadelphia.
Footnotes
Reprint requests to the Pulmonology Section, Division of Allergy, Immunology, and Pulmonology, The Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104 (Dr Wilmott).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Lung Function from Infancy to the Preschool Years after Clinical Diagnosis of Cystic Fibrosis
Kozlowska et al.
Am. J. Respir. Crit. Care Med. 2008;178:42-49.
ABSTRACT
| FULL TEXT
Segregation is good for patients with cystic fibrosis
Conway
JRSM 2008;101:31-35.
FULL TEXT
Advancing Outcome Measures for the New Era of Drug Development in Cystic Fibrosis
Mayer-Hamblett et al.
Proc Am Thorac Soc 2007;4:370-377.
ABSTRACT
| FULL TEXT
Profile and factors determining outcome in a cohort of cystic fibrosis patients seen at the aga khan university hospital, karachi, pakistan.
Shah et al.
J Trop Pediatr 2006;52:132-135.
ABSTRACT
| FULL TEXT
Bronchopulmonary Disease in Children with Cystic Fibrosis after Early or Delayed Diagnosis
Farrell et al.
Am. J. Respir. Crit. Care Med. 2003;168:1100-1108.
ABSTRACT
| FULL TEXT
|